Jiangfeng Mao

Jiangfeng Mao


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
JMJiangfeng Mao
Jiangfeng Mao
YLYuan-Yuan Li
Yuan-Yuan Li
RXRui Xiao
Rui Xiao
CLCai-Ping Li
Cai-Ping Li
JHJian Huangfu
Jian Huangfu
The aim of this study was to investigate the relationship between plasma fatty acid binding protein 4 (FABP4), phosphatase and tensin homolog (PTEN), and insulin resistance in patients with gestational diabetes mellitus (GDM). Plasma FABP4 and PTEN were determined by ELISA in GDM patients (GDM group, n=30) and in euglycemic pregnant women (control group, n=30). The clinical features, body mass index (BMI), homeostasis model assessment of insulin resistance (HOMA-IR), and lipid profiles were compared between the 2 groups. The influence of risk factors on insulin resistance, including BMI, lipid profiles, FABP4, and PTEN, were further investigated by multiple-factor stepwise regression analysis. Higher levels of BMI, ΔBMI, triglyceride (TG), fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG), fasting insulin, HOMA-IR, FABP4, PTEN, and lower level of high-density lipoprotein cholesterol (HDL-C) were found in the GDM patients than in the controls (all P<0.005). The plasma FABP4 was 1.47±0.25 vs. 0.20±0.07 ng/ml in the GDM and control group, respectively (P<0.0001). Plasma PTEN was 6.46±1.57 vs. 4.72±0.82 ng/ml in the GDM and control group, respectively (P<0.0001). There was a positive relation between plasma FABP4 and PTEN when all blood samples, including GDM and control groups, were analyzed (P<0.05). The multiple-factor regression analysis revealed that plasma FABP4, TG, and PTEN were independent risk factors for increased insulin resistance. GDM patients have more severe insulin resistance compared to euglycemic pregnant women. Higher levels of plasma FABP4 and PTEN are associated with increased insulin resistance and may participate in the pathogenesis of insulin resistance during gestation.

1 November 2012 in Fertility and Sterility
Verified
Journal Article
Closed access
JMJiangfeng Mao
Jiangfeng Mao
XHXu Hong-Li
Xu Hong-Li
WXWu Xue-Yan
Wu Xue-Yan
NMNie Min
Nie Min
LSLu Shuang-Yu
Lu Shuang-Yu
LLLiao Liang-Ming
Liao Liang-Ming

24 August 2010 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
MNMin Nie
Min Nie
QZQ. Zhou
Q. Zhou
JMJiangfeng Mao
Jiangfeng Mao
SLShuangyu Lu
Shuangyu Lu
XWXueyan Wu
Xueyan Wu
Individuals with male karyotype (46,XY) affected by 5α-reductase type 2 deficiency, a rare autosomal recessive inherited disorder, can have an almost female phenotype or partially virilized external genitalia. Mutations in the steroid-5-α-reductase (SRD5A2) gene, leading to functional impairment of 5α-reductase type 2, are responsible for this disorder. Our present study analyzed SRD5A2 gene mutations in eight unrelated 46,XY Chinese patients with disorders of sex development. Direct sequencing of genomic DNA for SRD5A2 gene revealed the presence of one homozygous (p.Q6X) and seven compound heterozygous mutations (p.G203S/R227Q, p.L20P/R227Q, p.Q6X/p.A228V, p.C222Ffs232X/p.R246Q, p.W140X/F219Sfs278X, p.Q71X/L185Tfs192X and p.Q6X/p.N193S) in our patients. Among them, p.C222Ffs232X, p.A228V, p.Q71X, L185Tfs192X and p.W140X mutations have not been previously reported. These novel mutations may provide us new insights into the molecular mechanism of 5α-reductase type 2 deficiency. Seven out of eight patients had at least one variant in exon 4, and 8 of 12 (66.7%) mutations were located in exon 4. The expanded mutation database of the SRD5A2 gene should benefit patients in the diagnosis and treatment of this disease.

15 April 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
YGYinjie Gao
Yinjie Gao
LLLin Lu
Lin Lu
BYBingqing Yu
Bingqing Yu
JMJiangfeng Mao
Jiangfeng Mao
XWXi Wang
Xi Wang
XWXueyan Wu
Xueyan Wu
Purpose Defects in both CYP21A2 and TNXB genes can cause congenital adrenal hyperplasia combined with hypermobility type Ehlers-Danlos syndrome, which has recently been named CAH-X syndrome. The purpose of this study is to assess the prevalence of chimeric TNXA/TNXB gene and clinical symptoms in a Chinese cohort with 21-hydroxylase deficiency (21-OHD). Methods A total of 424 patients with 21-OHD who were genetically diagnosed were recruited for this study. Multiplex ligation dependent probe amplification and sequencing were used to identify the CAH-X genotype. Clinical features of joints, skin, and others systems were evaluated in 125 patients. Results Here, 94 of the 424 patients had a deletion on at least one allele of CYP21A2 and 59 of them harbored heterozygotic TNXA/TNXB chimera. Frequencies of CAH-X CH-1, CH-2, and CH-3 were 8.2%, 3.1%, and 2.6%, respectively. The incidences of clinical features of EDS were 71.0% and 26.6% in patients with chimeric TNXA/TNXB genes or without (p<0.001). There were statistically significant differences in manifestations among the articular (p<0.001 in generalized hypermobility) and dermatologic (p<0.001 in hyperextensible skin, p=0.015 in velvety skin and p=0.033 in poor wound healing). The prevalence of generalized hypermobility was more common in CAH-X CH-2 or CH-3 than CH-1 patients (60% vs 20%, P=0.028). Conclusions In summary, about 14% of patients with 21-OHD may have chimeric TNXA/TNXB gene mutations in our study and most of them showed EDS related clinical symptoms. The correlation between CAH-X genotypes and clinical features in connective tissue like joint or skin needs to be further investigated.

11 February 2017 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
XWXiaojing Wang
Xiaojing Wang
WLWei Li
Wei Li
LMLiangkun Ma
Liangkun Ma
FPFan Ping
Fan Ping
JLJuntao Liu
Juntao Liu
MNMin Nie
Min Nie

2 November 2023 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
SLShuying Li
Shuying Li
LFLi Feng
Li Feng
JDJie Ding
Jie Ding
WZWeihong Zhou
Weihong Zhou
TYTangbin Yuan
Tangbin Yuan
JMJiangfeng Mao
Jiangfeng Mao
Background: Non-alcoholic fatty liver disease (NAFLD) is easily neglected in the non-obese population. TyG index (triglyceride glucose Index) and TG/HDL-c (triglyceride to high-density lipoprotein cholesterol) are new indicators to evaluate insulin resistance (IR). Fibroscan is a non-invasive way to assess hepatic steatosis [by control attenuation parameters (CAP)] and fibrosis [by liver stiffness measurement (LSM)].The purpose of this study was to explore the correlation of TyG and its combination with obesity indicators [TyG-waist circumference (WC), TyG-body mass index (BMI)] and TG/HDL-c with CAP and LSM. Method: One thousand seven hundred seventy-six adults (age ≥ 20 years, BMI < 30 kg/m2) in the National Health and Nutrition Examination Survey (NHANES) 2017–2018 were included. The correlations of CAP and LSM to the indexes were assessed by generalized linear models.. Receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic capability of the indicators on NAFLD and liver stiffness. Results: Survey-weighted percentage of NAFLD in non-obese was 38.6%. In the fully adjusted models, there were positive associations of TyG, TyG-BMI, TyG-WC and TG/HDL-c to CAP, with the βs of 24.810, 0.704, 0.29 and 2.983 (all p < 0.05), respectively. There were positive associations of TyG, TyG-BMI, TyG-WC, and TG/HDL-c to NAFLD, with ORs of 3.387, 1.03, 1.010 and 1.281 ((all p < 0.05)).The positive association was detected for TG/HDL-c and TyG-WC and LSM with βs of 0.057 and 0.004(p = 0.021 and p = 0.003).TyG-WC were positively associated with liver stiffness with OR of 1.006(95%CI = 1.002, 1.012). Furthermore, the TyG-WC had the strongest diagnostic capability (ROC = 0.806; 95%CI: 0.785–0.826) on NAFLD in non-obese participants, with a specificity of 0.737 and sensitivity of 0.746. Conclusion: In US non-obese population, the TyG, TyG-BMI, TyG-WC, and TG/HDL-c are positively correlated with CAP and NAFLD. TyG-WC has clinical importance in identifying NAFLD in the non-obese population.